5-tri-n-butylstannyl-2-dimethylaminopyrimidine | 579525-47-6

• 分子结构分类: 有机化合物 - 有机氮化合物
• 英文名称: 5-tri-n-butylstannyl-2-dimethylaminopyrimidine
• 英文别名: N,N-dimethyl-5-(tributylstannyl)pyrimidin-2-amine；N,N-dimethyl-5-tributylstannylpyrimidin-2-amine
• CAS: 579525-47-6
• 化学式: C₁₈H₃₅N₃Sn
• 分子量: 412.206
• InChiKey: ONMHHQDOZBAMAU-UHFFFAOYSA-N

物化性质

• 沸点：
  434.3±55.0 °C(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  4.6
• 重原子数：
  22
• 可旋转键数：
  11
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.78
• 拓扑面积：
  29
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  5-tri-n-butylstannyl-2-dimethylaminopyrimidine 在 aluminum oxide 、 bis-triphenylphosphine-palladium(II) chloride 作用下， 以 甲醇 为溶剂， 生成 2-((6-(2-(dimethylamino)pyrimidin-5-yl)pyridin-3-yl)methylene)malononitrile
  参考文献：
  名称：

  Rational design of molecular rotor-based fluorescent probes with bi-aromatic rings for efficient in vivo detection of amyloid-β plaques in Alzheimer's disease

  摘要：

  DOI：

  10.1016/j.ejmech.2022.114715
• 作为产物：
  描述：

  三丁基氯化锡 、 5-溴-2-(二甲基氨基)嘧啶 在 正丁基锂 作用下， 以 四氢呋喃 、 正己烷 为溶剂， 反应 3.75h， 以74%的产率得到5-tri-n-butylstannyl-2-dimethylaminopyrimidine
  参考文献：
  名称：

  ANTI-MALIGNANT TUMOR AGENT COMPOSITION

  摘要：

  公开号：

  EP2959918B1

文献信息

• Aromatic amino acid derivates and medicinal compositions
  申请人：Endo Hitoshi

  公开号：US20050119256A1

  公开（公告）日：2005-06-02

  1. An aromatic amino acid derivative represented by the formula (I) or its pharmacologically acceptable salt: wherein, R 1 is a hydrogen atom or an amino-protecting group, R 2 is a halogen atom or an alkyl, aralkyl or aryl group, R 3 is circle over (1)} a hydrogen atom, circle over (2)} an aroylamino group, circle over (3)} a phenyl group substituted with lower alkyl, phenyl, phenoxy, etc. circle over (4)} a naphthyl or tetrahydronaphthyl group optionally substituted with hydroxy, lower alkoxy or di(lower)alkylamino, circle over (5)} an unsaturated mono-cyclic heterocyclic group containing N, O and/or S substituted with lower alkyl, phenyl, naphthyl or tetrahydroquinolyl, circle over (6)} an unsaturated or partially saturated condensed heterocyclic group containing N, O and/or S, optionally substituted with oxo, carboxy, amino, lower alkyl, etc.; X is a halogen atom, an alkyl group or an alkoxy group; Y is oxygen atom or nitrogen atom; I is 0 or 1; m is 0, 1 or 2; n is an integer of 0-5. This compound can inhibit a transporter (LAT1) of essential amino acid which is one of main nutrition for cancer cells and accordingly cause drain of the essential amino acid on the cancer cells and finally can prohibit the multiplication of cancer cells.

  一种芳香族氨基酸衍生物，其化学式为（I）或其药理学上可接受的盐：其中，R1为氢原子或氨基保护基；R2为卤素原子或烷基、芳基烷基或芳基基团；R3为circle over (1)}氢原子，circle over (2)}芳基氨基基团，circle over (3)}苯基，其取代基为较低的烷基、苯基、苯氧基等，circle over (4)}萘基或四氢萘基，可选地取代羟基、较低的烷氧基或二（较低）烷基氨基，circle over (5)}含N、O和/或S的不饱和单环杂环基团，取代基为较低的烷基、苯基、萘基或四氢喹啉基团，circle over (6)}含N、O和/或S的不饱和或部分饱和的紧缩杂环基团，可选地取代为氧代、羧基、氨基、较低的烷基等；X为卤素原子、烷基或烷氧基；Y为氧原子或氮原子；I为0或1；m为0、1或2；n为0-5的整数。该化合物可以抑制癌细胞的主要营养物质之一的必需氨基酸转运体（LAT1），从而导致癌细胞必需氨基酸的流失，最终可以抑制癌细胞的增殖。
• Aromatic amino acid derivatives and medicinal compositions
  申请人：——

  公开号：US07345068B2

  公开（公告）日：2008-03-18

  1. An aromatic amino acid derivative represented by the formula (I) or its pharmacologically acceptable salt: wherein, R1 is a hydrogen atom or an amino-protecting group, R2 is a halogen atom or an alkyl, aralkyl or aryl group, R3 is circle around (1)} a hydrogen atom, circle around (2)} an aroylamino group, circle around (3)} a phenyl group substituted with lower alkyl, phenyl, phenoxy, etc. circle around (4)} a naphthyl or tetrahydronaphthyl group optionally substituted with hydroxy, lower alkoxy or di(lower)alkylamino, circle around (5)} an unsaturated mono-cyclic heterocyclic group containing N, O and/or S substituted with lower alkyl, phenyl, naphthyl or tetrahydroquinolyl, circle around (6)} an unsaturated or partially saturated condensed heterocyclic group containing N, O and/or S, optionally substituted with oxo, carboxy, amino, lower alkyl, etc.; X is a halogen atom, an alkyl group or an alkoxy group; Y is oxygen atom or nitrogen atom; l is 0 or 1; m is 0, 1 or 2; n is an integer of 0-5. This compound can inhibit a transporter (LAT1) of essential amino acid which is one of main nutrition for cancer cells and accordingly cause drain of the essential amino acid on the cancer cells and finally can prohibit the multiplication of cancer cells.

  一种芳香族氨基酸衍生物，其化学式为（I）或其药学上可接受的盐：其中，R1是氢原子或氨基保护基，R2是卤素原子或烷基、芳基烷基或芳基基团，R3是圆圈1}氢原子，圆圈2}芳酰氨基基团，圆圈3}苯基取代较低烷基、苯基、苯氧基等的基团，圆圈4}萘基或四氢萘基基团，可选地取代羟基、较低烷氧基或二（较低）烷基氨基，圆圈5}含有N、O和/或S的不饱和单环杂环基团，取代较低烷基、苯基、萘基或四氢喹啉基团，圆圈6}含有N、O和/或S的不饱和或部分饱和的紧缩杂环基团，可选地取代氧代、羧基、氨基、较低烷基等；X是卤素原子、烷基或烷氧基；Y是氧原子或氮原子；l为0或1；m为0、1或2；n为0-5的整数。该化合物可以抑制癌细胞的主要营养物质之一的必需氨基酸的转运体（LAT1），从而导致癌细胞中必需氨基酸的流失，最终可以抑制癌细胞的增殖。
• SPIRO CONDENSED BARBITURIC ACID DERIVATIVES FOR USE AS ANTIBACTERIAL
  申请人：Basarab Gregory Steven

  公开号：US20110178064A1

  公开（公告）日：2011-07-21

  In one aspect, the present invention relates to compounds of Formula (I): to pharmaceutically acceptable salts thereof, to methods of using them to treat bacterial infections, and to method for their preparation.

  在一个方面，本发明涉及到式(I)的化合物，其药学上可接受的盐，以及使用它们治疗细菌感染的方法和它们的制备方法。
• AROMATIC AMINO ACID DERIVATIVES AND MEDICINAL COMPOSITIONS
  申请人：Endo, Hitoshi

  公开号：EP1481965B1

  公开（公告）日：2015-07-29